Inhibition of S6 Kinase activity for the treatment of insulin resistance
Auwerx, J.; Frigerio, F.; Fumagalli, S.; Kozma, S.; Picard, F.; Sticker-Jantscheff, M.; Thomas, G.; Um, S.H.; Watanabe, M.
2005

Abstract

This invention provides screening methods for agents effective in treating insulin resistance through specific inhibition of S6 kinase 1 activity. Also provided are methods of treating insulin resistance by administering an effective amount of an inhibitor specific for S6 kinase 1

Details

Title Inhibition of S6 Kinase activity for the treatment of insulin resistance
Author(s) Auwerx, J. ; Frigerio, F. ; Fumagalli, S. ; Kozma, S. ; Picard, F. ; Sticker-Jantscheff, M. ; Thomas, G. ; Um, S.H. ; Watanabe, M.
Date 2005
Note Applicant(s): Novartis Forschungsstiftung [CH]
Alternative title(s) : (de) Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz (fr) Inhibition de l'activite de la kinase s6 pour traiter la resistance a l'insuline (en) Inhibition of s6 kinase activity for the treatment of insulin resistance
Other identifier(s) EPO Family ID: 34216100
Patent number(s) ES2331006 (T3)
DE602004022423 (D1)
AT438859 (T)
EP1658504 (B1)
US2007191259 (A1)
JP2007503203 (A)
EP1658504 (A1)
WO2005019829 (A1)
Laboratories NCEM
Record Appears in Scientific production and competences > SV - School of Life Sciences > IBI-SV - Interfaculty Institute of Bioengineering > NCEM - Nestlé Chair in Energy Metabolism
Work outside EPFL
Patents
Record creation date 2009-04-20

Actions